Resources

The AxoSim Team will be on the road for the Society of Neuroscience 2022 Annual Meeting in San Diego, CA. We are excited to have two poster presentations and our CEO Lowry Curley, PhD, will […]

Meet AxoSim Research Scientist Lise Harbom, PhD Tell us about yourself. I attended Vanderbilt University for undergraduate studies where I double majored in Neuroscience and French. I also graduated with honors in Neuroscience, completing an […]

Check out AxoSim CEO Lowry Curley PhD, and Obatala Sciences CEO Trivia Frazier’s, PhD, MBA, op-ed highlighting their experiences growing companies in Southeast Louisiana and how important funding is for the BioDistrict for future growth and success. Nola.com Letters: BioDistrict will […]

Dear Colleagues and Friends, 2022 has been busy and productive for all of us on the AxoSim team. In particular, we have made great progress on our strategic focus for 2022, our NerveSim® peripheral neuropathy […]

Check out The Tech Tribune’s Q&A piece with our Co-Founder Michael J. Moore, PhD. AxoSim is honored to be featured three years running as one of Tech Tribune’s best start ups in Louisiana. Tell us […]

AxoSim Lead Scientist Corey Rountree, PhD, recaps his experiences from the inaugural MPS World Summit held in New Orleans in May 2022. Tell us about your experience at the MPS World Summit. The MPS World […]

Angela Cheramie was born in 1960 in Galliano, Louisiana, about an hour and half south of New Orleans.  She was adopted at birth and has one sister. Growing up, her dad owned a small hardware […]

From May 30 to June 3, AxoSim is a sponsor and co-host of the inaugural MPS World Summit which we are honored to have in our hometown of New Orleans. We hope that you can join us and would […]

We are proud to announce our published paper: Morphine-sensitive synaptic transmission emerges in embryonic rat microphysiological model of lower afferent nociceptive signaling in Science Advances. The work is a collaboration between the academic lab of […]

Blog written by AxoSim Research Assistant Sabrina Dillon March marks Multiple Sclerosis (MS) Awareness Month. MS is a demyelinating disease concerning the central nervous system (CNS). In 2020, approximately 2.8 million individuals were afflicted with […]